Rett Syndrome Completed Phase 2 / 3 Trials for Trofinetide (DB06045)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04988867An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett SyndromeTreatment